Trials / Withdrawn
WithdrawnNCT00399204
Comparison of Cardiovascular Outcomes of Pioglitazone and Metformin in Type 2 Diabetes Patients
A Randomised Pilot Study to Compare the Effect of Pioglitazone and Metformin on Cardiovascular Morbidity and Mortality in Patients With Type 2 Diabetes
- Status
- Withdrawn
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Post Graduate Institute of Medical Education and Research, Chandigarh · Academic / Other
- Sex
- All
- Age
- 25 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
The study aims to see if there is any significant difference in the cardiovascular outcomes in type 2 diabetes patients who are treated with pioglitazone or Metformin
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Pioglitazone vs Metformin |
Timeline
- Start date
- 2006-01-01
- Primary completion
- 2012-12-01
- Completion
- 2012-12-01
- First posted
- 2006-11-14
- Last updated
- 2019-03-20
Locations
1 site across 1 country: India
Source: ClinicalTrials.gov record NCT00399204. Inclusion in this directory is not an endorsement.